AZD9592: Clinical Trials

1 trial of AZD9592, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow AZD9592: new trials by email Literature Review of AZD9592 trials Research Report on AZD9592

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First in Human Study of AZD9592 in Solid Tumors
AZD9592, Osimertinib, 5-Fluorouracil (5-FU) - Advanced Solid Tumours, Carcinoma Non-small Cell Lung
Phase 1Active not recruitingAstraZeneca1902022-12-212026-09-25

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Neoplasms (1)

Sponsors

AstraZeneca (1)

Countries

Australia (1)  ·  Canada (1)  ·  China (1)  ·  France (1)  ·  Italy (1)  ·  Japan (1)  ·  Malaysia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Charu Aggarwal, MD, MPH (1)